SCT-200
- Generic Name
- SCT-200
SCT200 in Combination With SCT-I10A/Paclitaxel/Docetaxel in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Phase 1
Recruiting
- Conditions
- Head and Neck Squamous Carcinoma
- Interventions
- First Posted Date
- 2022-09-23
- Last Posted Date
- 2022-09-23
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 120
- Registration Number
- NCT05552807
- Locations
- 🇨🇳
Shanghai East Hospital, Shanghai, China
Anti-EGFR Therapy With IMRT Concurrent Chemoradiotherapy in Locally Advanced OPC Resistant to Induction Chemotherapy
- First Posted Date
- 2020-08-11
- Last Posted Date
- 2022-04-04
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 52
- Registration Number
- NCT04508829
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
Clinical Trial to Evaluate Pharmacokinetics,Safety and Immunogenicity of Single Injection of CDP1 to Healthy Volunteers Compared to Erbitux
Phase 1
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2019-03-20
- Last Posted Date
- 2019-03-20
- Lead Sponsor
- Dragonboat Biopharmaceutical Company Limited
- Target Recruit Count
- 84
- Registration Number
- NCT03881787
- Locations
- 🇨🇳
Shanghai Public Health Clinical Center, Shanghai, Shanghai, China
🇨🇳West China Hospital, Chengdu, Sichuang, China
SCT200 Plus Platinum-based Chemotherapy in Head and Neck Squamous Cell Carcinoma
- First Posted Date
- 2019-03-14
- Last Posted Date
- 2020-05-27
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 25
- Registration Number
- NCT03874741
- Locations
- 🇨🇳
Cancer hospital Chinese academy of medical sciences, Beijing, Beijing, China
Efficacy and Safety of SCT200 in Patients With Advanced Squamous Non-small Cell Lung Cancer
- First Posted Date
- 2019-01-17
- Last Posted Date
- 2019-01-17
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 50
- Registration Number
- NCT03808701
SCT200 Injection in Patients With Head and Neck Squamous Cell Carcinoma
Phase 2
- Conditions
- Head and Neck Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2018-11-16
- Last Posted Date
- 2018-11-16
- Lead Sponsor
- Shi Yuankai
- Target Recruit Count
- 30
- Registration Number
- NCT03744208
Safety and Efficacy of SCT200 in Head and Neck Squamous Cell Carcinoma
- First Posted Date
- 2018-10-19
- Last Posted Date
- 2020-03-23
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT03713372
- Locations
- 🇨🇳
Cancer hospital Chinese academy of medical sciences, Beijing, Beijing, China
A Preliminary Clinical Study on the Pharmacokinetics and Safety of CDP1 in Patients With Advanced CRC or HNSCC
Phase 1
- Conditions
- Colorectal Cancer
- Interventions
- First Posted Date
- 2018-04-09
- Last Posted Date
- 2019-10-31
- Lead Sponsor
- Dragonboat Biopharmaceutical Company Limited
- Target Recruit Count
- 18
- Registration Number
- NCT03491709
- Locations
- 🇨🇳
Shanghai East Hospital Phase 1 Clinical Trial Center, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath